Sevgi Gurkan
InvestorFounderVenture Partner at OrbiMed · Board director at Perfuse Therapeutics
San Francisco Bay Area
Writes $1M – $75M checks · typically $4M
FoundedPerfuse Therapeutics
About
Sevgi Gurkan joined OrbiMed in 2018 as a Venture Partner. She was previously a founding member of Merck Research Laboratories' South San Francisco Discovery site and a Director in Early Drug Development at MRL. Earlier in her career she was an Associate Professor at Rutgers, Director of the Pediatric Kidney Transplant Program at RWJ University Hospital, and a pediatric nephrologist; she holds a medical degree from Hacettepe University and a Master of Science in Clinical Research from Mount Sinai School of Medicine.
Invests in
Biotech
Board director at Perfuse Therapeutics
Intro paths
In turn, Sevgi can intro founders to Perfuse Therapeutics's investors below.
Perfuse Therapeutics's investors · 7
Experience
- Stanford UniversitySPARK Advisorcurrent2025 — present
- Corteria PharmaceuticalsMember Board of Directorscurrent2023 — present
- Perfuse TherapeuticsFounder, President and CEOcurrent2018 — presentSan Francisco, California
- OrbiMedVenture Partnercurrent2018 — presentSan Francisco Bay Area
- MerckGroup Lead / Director / Discovery Biology South San Francisco2016 — 2018630 Gateway Blvd South San Francisco
- MerckMedical Director / Early Clinical Development2014 — 2016Rahway
- Rutgers UniversityAssociate Professor/Pediatric Nephrology2008 — 2016
- Robert Wood Johnson University HospitalDirector, Pediatric Kidney Transplant Center2013 — 2014
- Child Health Institute of New JerseyPhysician Scientist2010 — 2014New Brunswick, NJ
Education
- Icahn School of Medicine at Mount SinaiMaster's degree, Clinical Research2006 — 2008
- Icahn School of Medicine at Mount SinaiNephrology, Translational research on mechanisms of graft tolerance2005 — 2008
- University of Southern CaliforniaPediatrics2002 — 2005
- Hacettepe UniversityDoctor of Medicine (M.D.)1995 — 2001
- Ankara High School of Science
- Bornova Anadolu Lisesi (İzmir Koleji)
Skills & more
+12 more
ImmunologyTranslational ResearchTreatmentIn VitroIn VivoProtocolLaboratoryNephrologyInflammationAnimal ModelsCell CultureFlow CytometryLanguages English · Spanish · Turkish
From Sevgi's professional profile.
Colleagues at OrbiMed
Frequently asked questions
- Where does Sevgi Gurkan work?
- Sevgi Gurkan is Venture Partner at OrbiMed and Founder at Perfuse Therapeutics.
- What does Sevgi Gurkan invest in?
- Sevgi Gurkan invests in Biotech.
- What check size does Sevgi Gurkan write?
- Sevgi Gurkan typically writes checks of $1M – $75M.
- What companies did Sevgi Gurkan found?
- Sevgi Gurkan founded Perfuse Therapeutics.
Founder mafias
Stanford University mafia855
Also came through, then founded or led a company.
+ 848 more
University of Southern California mafia130
Also came through, then founded or led a company.
+ 123 more
OrbiMed mafia6
Also came through, then founded or led a company.
Icahn School of Medicine at Mount Sinai mafia5
Also came through, then founded or led a company.
Hacettepe University mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Southern California474
+ 468 more
Also attended Hacettepe University10
+ 4 more
Also attended Ankara High School of Science1
Also attended Bornova Anadolu Lisesi (İzmir Koleji)1
Shared employers
Also worked at Corteria Pharmaceuticals2
Also worked at Merck103
+ 97 more
Also worked at Rutgers University28
+ 22 more
